Trial Outcomes & Findings for Preoperative Application of Chlorhexidine to Reduce Infection With Cesarean Section After Labor (NCT NCT03423147)

NCT ID: NCT03423147

Last Updated: 2023-03-23

Results Overview

Surgical site infection will be a composite of wound infection and postpartum endometritis. Endometritis is defined as postoperative fever of 100.4 °F or more occurring 24 hours after delivery associated with uterine tenderness and persistent foul-smelling lochia, requiring broad-spectrum intravenous antibiotic administration. Wound infection is defined as erythema or wound edge separation with purulent discharge involving the cesarean incision site that requires antibiotic therapy and wound care.

Recruitment status

TERMINATED

Study phase

PHASE2

Target enrollment

319 participants

Primary outcome timeframe

up to 6 weeks postpartum

Results posted on

2023-03-23

Participant Flow

Recruitment and enrollment occurred between Oct 2018 and Feb 2021 at Mount Sinai Hospital's Labor and Delivery floor

Participant milestones

Participant milestones
Measure
Chlorhexidine Gluconate Vaginal Scrub and Cloth
Patients had a 2% chlorhexidine gluconate cloth applied to their abdomen as well as 4% chlorhexidine gluconate vaginal scrub applied as a vaginal cleanse in the operating room prior to cesarean section 2% chlorhexidine gluconate cloth: applied to their abdomen 4% Chlorhexidine gluconate vaginal scrub: applied as a vaginal cleanse in the operating room prior to cesarean section
Standard Treatment
Patients who are not in the intervention arm received the standard of care prior to a cesarean section. In the operating room the patient will receive an abdominal cleanse with 2% Chloraprep solution (2% chlorhexidine gluconate) in addition to routine IV antibiotics. 2% chlorhexidine gluconate cloth: applied to their abdomen
Overall Study
STARTED
160
159
Overall Study
COMPLETED
152
150
Overall Study
NOT COMPLETED
8
9

Reasons for withdrawal

Reasons for withdrawal
Measure
Chlorhexidine Gluconate Vaginal Scrub and Cloth
Patients had a 2% chlorhexidine gluconate cloth applied to their abdomen as well as 4% chlorhexidine gluconate vaginal scrub applied as a vaginal cleanse in the operating room prior to cesarean section 2% chlorhexidine gluconate cloth: applied to their abdomen 4% Chlorhexidine gluconate vaginal scrub: applied as a vaginal cleanse in the operating room prior to cesarean section
Standard Treatment
Patients who are not in the intervention arm received the standard of care prior to a cesarean section. In the operating room the patient will receive an abdominal cleanse with 2% Chloraprep solution (2% chlorhexidine gluconate) in addition to routine IV antibiotics. 2% chlorhexidine gluconate cloth: applied to their abdomen
Overall Study
Lost to Follow-up
5
8
Overall Study
Withdrawal by Subject
1
0
Overall Study
withdrawn due to vaginal delivery
1
0
Overall Study
Age < 18
1
0
Overall Study
No Trial of Labor
0
1

Baseline Characteristics

Preoperative Application of Chlorhexidine to Reduce Infection With Cesarean Section After Labor

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Chlorhexidine Gluconate Vaginal Scrub and Cloth
n=160 Participants
Patients had a 2% chlorhexidine gluconate cloth applied to their abdomen as well as 4% chlorhexidine gluconate vaginal scrub applied as a vaginal cleanse in the operating room prior to cesarean section 2% chlorhexidine gluconate cloth: applied to their abdomen 4% Chlorhexidine gluconate vaginal scrub: applied as a vaginal cleanse in the operating room prior to cesarean section
Standard Treatment
n=159 Participants
Patients who are not in the intervention arm received the standard of care prior to a cesarean section. In the operating room the patient will receive an abdominal cleanse with 2% Chloraprep solution (2% chlorhexidine gluconate) in addition to routine IV antibiotics. 2% chlorhexidine gluconate cloth: applied to their abdomen
Total
n=319 Participants
Total of all reporting groups
Age, Continuous
32.01 years
STANDARD_DEVIATION 6.10 • n=5 Participants
32.59 years
STANDARD_DEVIATION 5.43 • n=7 Participants
32.30 years
STANDARD_DEVIATION 5.77 • n=5 Participants
Sex: Female, Male
Female
160 Participants
n=5 Participants
159 Participants
n=7 Participants
319 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
32 Participants
n=5 Participants
30 Participants
n=7 Participants
62 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
98 Participants
n=5 Participants
108 Participants
n=7 Participants
206 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
30 Participants
n=5 Participants
21 Participants
n=7 Participants
51 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
15 Participants
n=5 Participants
16 Participants
n=7 Participants
31 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
25 Participants
n=5 Participants
28 Participants
n=7 Participants
53 Participants
n=5 Participants
Race (NIH/OMB)
White
64 Participants
n=5 Participants
67 Participants
n=7 Participants
131 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
45 Participants
n=5 Participants
35 Participants
n=7 Participants
80 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
11 Participants
n=5 Participants
12 Participants
n=7 Participants
23 Participants
n=5 Participants

PRIMARY outcome

Timeframe: up to 6 weeks postpartum

Surgical site infection will be a composite of wound infection and postpartum endometritis. Endometritis is defined as postoperative fever of 100.4 °F or more occurring 24 hours after delivery associated with uterine tenderness and persistent foul-smelling lochia, requiring broad-spectrum intravenous antibiotic administration. Wound infection is defined as erythema or wound edge separation with purulent discharge involving the cesarean incision site that requires antibiotic therapy and wound care.

Outcome measures

Outcome measures
Measure
Chlorhexidine Gluconate Vaginal Scrub and Cloth
n=160 Participants
Patients had a 2% chlorhexidine gluconate cloth applied to their abdomen as well as 4% chlorhexidine gluconate vaginal scrub applied as a vaginal cleanse in the operating room prior to cesarean section 2% chlorhexidine gluconate cloth: applied to their abdomen 4% Chlorhexidine gluconate vaginal scrub: applied as a vaginal cleanse in the operating room prior to cesarean section
Standard Treatment
n=159 Participants
Patients who are not in the intervention arm received the standard of care prior to a cesarean section. In the operating room the patient will receive an abdominal cleanse with 2% Chloraprep solution (2% chlorhexidine gluconate) in addition to routine IV antibiotics. 2% chlorhexidine gluconate cloth: applied to their abdomen
Number of Participants With Surgical Site Infection
12 Participants
22 Participants

SECONDARY outcome

Timeframe: up to 6 weeks postpartum

Outcome measures

Outcome measures
Measure
Chlorhexidine Gluconate Vaginal Scrub and Cloth
n=160 Participants
Patients had a 2% chlorhexidine gluconate cloth applied to their abdomen as well as 4% chlorhexidine gluconate vaginal scrub applied as a vaginal cleanse in the operating room prior to cesarean section 2% chlorhexidine gluconate cloth: applied to their abdomen 4% Chlorhexidine gluconate vaginal scrub: applied as a vaginal cleanse in the operating room prior to cesarean section
Standard Treatment
n=159 Participants
Patients who are not in the intervention arm received the standard of care prior to a cesarean section. In the operating room the patient will receive an abdominal cleanse with 2% Chloraprep solution (2% chlorhexidine gluconate) in addition to routine IV antibiotics. 2% chlorhexidine gluconate cloth: applied to their abdomen
Number of Participants With Maternal Complications or Interventions
7 Participants
1 Participants

SECONDARY outcome

Timeframe: up to 6 weeks postpartum

Number of participants with newborn with neonatal ICU admissions

Outcome measures

Outcome measures
Measure
Chlorhexidine Gluconate Vaginal Scrub and Cloth
n=160 Participants
Patients had a 2% chlorhexidine gluconate cloth applied to their abdomen as well as 4% chlorhexidine gluconate vaginal scrub applied as a vaginal cleanse in the operating room prior to cesarean section 2% chlorhexidine gluconate cloth: applied to their abdomen 4% Chlorhexidine gluconate vaginal scrub: applied as a vaginal cleanse in the operating room prior to cesarean section
Standard Treatment
n=159 Participants
Patients who are not in the intervention arm received the standard of care prior to a cesarean section. In the operating room the patient will receive an abdominal cleanse with 2% Chloraprep solution (2% chlorhexidine gluconate) in addition to routine IV antibiotics. 2% chlorhexidine gluconate cloth: applied to their abdomen
Number of Participants With Neonatal ICU Admissions
30 Participants
36 Participants

SECONDARY outcome

Timeframe: up to 6 weeks postpartum

Outcome measures

Outcome measures
Measure
Chlorhexidine Gluconate Vaginal Scrub and Cloth
n=160 Participants
Patients had a 2% chlorhexidine gluconate cloth applied to their abdomen as well as 4% chlorhexidine gluconate vaginal scrub applied as a vaginal cleanse in the operating room prior to cesarean section 2% chlorhexidine gluconate cloth: applied to their abdomen 4% Chlorhexidine gluconate vaginal scrub: applied as a vaginal cleanse in the operating room prior to cesarean section
Standard Treatment
n=159 Participants
Patients who are not in the intervention arm received the standard of care prior to a cesarean section. In the operating room the patient will receive an abdominal cleanse with 2% Chloraprep solution (2% chlorhexidine gluconate) in addition to routine IV antibiotics. 2% chlorhexidine gluconate cloth: applied to their abdomen
Maternal Length of Stay
2.98 days
Standard Deviation 1.24
2.93 days
Standard Deviation 0.78

SECONDARY outcome

Timeframe: up to 6 weeks postpartum

Outcome measures

Outcome measures
Measure
Chlorhexidine Gluconate Vaginal Scrub and Cloth
n=160 Participants
Patients had a 2% chlorhexidine gluconate cloth applied to their abdomen as well as 4% chlorhexidine gluconate vaginal scrub applied as a vaginal cleanse in the operating room prior to cesarean section 2% chlorhexidine gluconate cloth: applied to their abdomen 4% Chlorhexidine gluconate vaginal scrub: applied as a vaginal cleanse in the operating room prior to cesarean section
Standard Treatment
n=159 Participants
Patients who are not in the intervention arm received the standard of care prior to a cesarean section. In the operating room the patient will receive an abdominal cleanse with 2% Chloraprep solution (2% chlorhexidine gluconate) in addition to routine IV antibiotics. 2% chlorhexidine gluconate cloth: applied to their abdomen
Number of Participants With Readmissions
6 Participants
2 Participants

SECONDARY outcome

Timeframe: Day 1

Outcome measures

Outcome measures
Measure
Chlorhexidine Gluconate Vaginal Scrub and Cloth
n=160 Participants
Patients had a 2% chlorhexidine gluconate cloth applied to their abdomen as well as 4% chlorhexidine gluconate vaginal scrub applied as a vaginal cleanse in the operating room prior to cesarean section 2% chlorhexidine gluconate cloth: applied to their abdomen 4% Chlorhexidine gluconate vaginal scrub: applied as a vaginal cleanse in the operating room prior to cesarean section
Standard Treatment
n=159 Participants
Patients who are not in the intervention arm received the standard of care prior to a cesarean section. In the operating room the patient will receive an abdominal cleanse with 2% Chloraprep solution (2% chlorhexidine gluconate) in addition to routine IV antibiotics. 2% chlorhexidine gluconate cloth: applied to their abdomen
Estimated Blood Loss
671 mL
Standard Deviation 389
670 mL
Standard Deviation 391

SECONDARY outcome

Timeframe: Day 1

Population: Data not collected

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Day 1

Outcome measures

Outcome measures
Measure
Chlorhexidine Gluconate Vaginal Scrub and Cloth
n=160 Participants
Patients had a 2% chlorhexidine gluconate cloth applied to their abdomen as well as 4% chlorhexidine gluconate vaginal scrub applied as a vaginal cleanse in the operating room prior to cesarean section 2% chlorhexidine gluconate cloth: applied to their abdomen 4% Chlorhexidine gluconate vaginal scrub: applied as a vaginal cleanse in the operating room prior to cesarean section
Standard Treatment
n=159 Participants
Patients who are not in the intervention arm received the standard of care prior to a cesarean section. In the operating room the patient will receive an abdominal cleanse with 2% Chloraprep solution (2% chlorhexidine gluconate) in addition to routine IV antibiotics. 2% chlorhexidine gluconate cloth: applied to their abdomen
Length of Operation
61-90 minutes
87 Participants
96 Participants
Length of Operation
91+ minutes
27 Participants
17 Participants
Length of Operation
45-60 minutes
46 Participants
46 Participants

Adverse Events

Chlorhexidine Gluconate Vaginal Scrub and Cloth

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Standard Treatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Nicola Tavella

Icahn School of Medicine at Mount Sinai

Phone: 212-241-3888

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place